Abstract
Background
Adenoid cystic carcinoma (ACC) of the breast is a rare type of breast cancer, which presents inconsistencies in the optimal management strategy.
Methods
A retrospective review of prospectively collected data, spanning the last 20 years, was performed using the cancer registry database at our institution.
Results
Six patients were diagnosed with ACC of the breast, out of 5,813 total patients diagnosed with breast cancer (0.1%). Our identified patients had a median age of 66, all with the early stage cancer (Stage I/II). The average size of the breast lesion was 1.62 cm, and nodal status was negative for all cases. All patients had resection as primary therapy (partial or total mastectomy), with one patient also undergoing external beam radiation and tamoxifen hormonal therapy. Median follow-up was 85 months, with all patients being disease-free at last follow-up.
Conclusions
ACC of the breast has an indolent course, despite triple negative status. Our study suggests that radiation may not be warranted and confirms the rarity of axillary node metastases, indicating that sentinel node excision may also not be necessary. Ultimately, the hope is that our findings along with the reviewed literature will aid in determining the most appropriate options for management of ACC of the breast.
Similar content being viewed by others
References
Boujelbene N, Khabir A, Jeanneret Sozzi W, Mirimanoff RO, Khanfir K. Clinical review—breast adenoid cystic carcinoma. Breast. 2011;53:2124–9. doi:10.1016/j.breast.2011.11.006.
Sumpio BE, Jennings TA, Merino MJ, Sullivan PD. Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann Surg. 1987;205:295–301.
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, World Health Organization, et al. WHO classification of tumours of the breast. Lyon: IARC; 2012.
Kulkarni N, Pezzi CM, Greif JM, Suzanne Klimberg V, Bailey L, Korourian S, et al. Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base. Ann Surg Oncol. 2013;20:2236–41. doi:10.1245/s10434-013-2911-z.
Li N, Xu L, Zhao H, El-Naggar AK, Sturgis EM. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the surveillance, epidemiology, and end results registry. Cancer. 2012;118:3945–53. doi:10.1002/cncr.26740.
Cadoo KA, McArdle O, O’Shea A-M, Power CP, Hennessy BT. Management of unusual histological types of breast cancer. Oncologist. 2012;17:1135–45. doi:10.1634/theoncologist.2012-0134.
Tang P, Yang S, Zhong X, Yao J, Zhang Y, Dong H, et al. Breast adenoid cystic carcinoma in a 19-year-old man: a case report and review of the literature. World J Surg Oncol. 2015;13:19. doi:10.1186/s12957-015-0442-8.
American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 7th ed. Springer, Berlin; 2010. doi:10.1007/978-0-387-88443-1.
Canyilmaz E, Uslu GH, Memış Y, Bahat Z, Yildiz K, Yoney A. Adenoid cystic carcinoma of the breast: a case report and literature review. Oncol Lett. 2014;7:1599–601. doi:10.3892/ol.2014.1945.
Miyai K, Schwartz MR, Divatia MK, Anton RC, Park YW, Ayala AG, et al. Adenoid cystic carcinoma of breast: recent advances. World J Clin Cases. 2014;2:732–41. doi:10.12998/wjcc.v2.i12.732.
Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM. Adenoid cystic carcinoma of the breast in the United States (1977–2006): a population-based cohort study. Breast Cancer Res. 2010;12:R54. doi:10.1186/bcr2613.
Kshirsagar AY, Wader JV, Langade YB, Jadhav KP, Zaware SU, Shekhar N. Adenoid cystic carcinoma of the male breast. Int Surg. 2006;91:234–6.
Hjorth S, Magnusson PH, Blomquist P. Adenoid cystic carcinoma of the breast. Report of a case in a male and review of the literature. Acta Chir Scand. 1977;143:155–8.
Tang W, Peng WJ, Gu YJ, Zhu H, Jiang TT, Li C. Imaging manifestation of adenoid cystic carcinoma of the breast. J Comput Assist Tomogr. 2015;39:523–30. doi:10.1097/RCT.0000000000000236.
McClenathan JH, de la Roza G. Adenoid cystic breast cancer. Am J Surg. 2002;183:646–9.
Ikeda D. Breast imaging: the requisites. 2nd ed. St. Louis, MO: Mosby; 2011.
Cardenosa G. Breast imaging companion. 3rd ed. Philadelphia: LWW; 2008.
Santamaría G, Velasco M, Zanón G, Farrús B, Molina R, Solé M, et al. Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol. 1998;171:1679–83. doi:10.2214/ajr.171.6.9843312.
Tsuboi N, Ogawa Y, Inomata T, Nishioka A, Yoshida D, Yoshida S, et al. Dynamic MR appearance of adenoid cystic carcinoma of the breast in a 67-year-old female. Radiat Med. 1998;16:225–8.
Kasagawa T, Suzuki M, Doki T, Fujimori T, Itami M, Takenouchi T, et al. Two cases of adenoid cystic carcinoma: preoperative cytological findings were useful in determining treatment strategy. Breast Cancer. 2006;13:112–6.
Santamaría G, Velasco M, Bargalló X, Caparrós X, Farrús B, Luis Fernández P. Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images. Radiographics. 2010;30:533–48. doi:10.1148/rg.302095044.
Glazebrook KN, Reynolds C, Smith RL, Gimenez EI, Boughey JC. Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol. 2010;194:1391–6. doi:10.2214/AJR.09.3545.
Wetterskog D, Lopez-Garcia MA, Lambros MB, A’Hern R, Geyer FC, Milanezi F, et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 2012;226:84–96. doi:10.1002/path.2974.
Brill LB, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24:1169–76. doi:10.1038/modpathol.2011.86.
Azoulay S, Laé M, Fréneaux P, Merle S, Al Ghuzlan A, Chnecker C, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18:1623–31. doi:10.1038/modpathol.3800483.
Rosen PP. Adenoid cystic carcinoma. Rosen’s breast pathol. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 590–604.
Crisi GM, Marconi SA, Makari-Judson G, Goulart RA. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;124:733–9. doi:10.1309/61MV-ENEK-5EJ7-JKGF.
Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24:157–67. doi:10.1038/modpathol.2010.200.
Foschini MP, Rizzo A, De Leo A, Laurino L, Sironi M, Rucco V. Solid variant of adenoid cystic carcinoma of the breast: a case series with proposal of a new grading system. Int J Surg Pathol. 2016;24:97–102. doi:10.1177/1066896915606973.
Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, et al. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 2010;41:1617–23. doi:10.1016/j.humpath.2010.04.013.
Vranic S, Bender R, Palazzo J, Gatalica Z. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics. Hum Pathol. 2013;44:301–9. doi:10.1016/j.humpath.2012.01.002.
Marchiò C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or “The strange case of Dr Jekyll and Mr Hyde” of exocrine gland carcinomas). J Clin Pathol. 2010;63:220–8. doi:10.1136/jcp.2009.073908.
Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer. 2002;94:2119–27. doi:10.1002/cncr.10455.
Hill PA. c-kit expression in adenoid cystic carcinoma of the breast. Pathology. 2004;36:362–4. doi:10.1080/00313020410001721537.
Mastropasqua MG, Maiorano E, Pruneri G, Orvieto E, Mazzarol G, Vento AR, et al. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol. 2005;18:1277–82. doi:10.1038/modpathol.3800423.
Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol. 1987;18:1276–81.
Khanfir K, Kallel A, Villette S, Belkacémi Y, Vautravers C, Nguyen T, et al. Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012;82:2118–24. doi:10.1016/j.ijrobp.2010.12.008.
Thompson K, Grabowski J, Saltzstein SL, Sadler GR, Blair SL. Adenoid cystic breast carcinoma: is axillary staging necessary in all cases? Results from the California Cancer Registry. Breast J. 2011;17:485–9. doi:10.1111/j.1524-4741.2011.01117.x.
Millar BM, Kerba M, Youngson B, Lockwood GA, Liu F-F. The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast. Breast Cancer Res Treat. 2004;87:225–32. doi:10.1007/s10549-004-8693-z.
Franzese C, Zei G, Masoni T, Cecchini S, Monteleone E, Livi L, et al. Adenoid cystic carcinoma of the breast. The double face of an exocrine gland carcinoma. Strahlentherapie Und Onkol Organ Der Dtsch Röntgengesellschaft. [et Al] 2013;189:1049–50. doi:10.1007/s00066-013-0461-8.
Coates JM, Martinez SR, Bold RJ, Chen SL. Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol. 2010;102:342–7. doi:10.1002/jso.21638.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they do not have conflict of interest.
About this article
Cite this article
Treitl, D., Radkani, P., Rizer, M. et al. Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature. Breast Cancer 25, 28–33 (2018). https://doi.org/10.1007/s12282-017-0780-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-017-0780-1